Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E - Archive ouverte HAL Access content directly
Journal Articles Oncogene Year : 2010

Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E

, , , , , (1) , , , , , , , ,
1
C Andrieu
  • Function : Author
D Taieb
  • Function : Author
V Baylot
  • Function : Author
S Ettinger
  • Function : Author
P Soubeyran
  • Function : Author
C Nelson
  • Function : Author
C Garrido
  • Function : Author
A So
  • Function : Author
L Fazli
  • Function : Author
F Bladou
  • Function : Author
M Gleave
  • Function : Author
J Iovanna
  • Function : Author
P Rocchi
  • Function : Author

Dates and versions

hal-03030324 , version 1 (30-11-2020)

Identifiers

Cite

C Andrieu, D Taieb, V Baylot, S Ettinger, P Soubeyran, et al.. Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E. Oncogene, 2010, 29 (13), pp.1883-1896. ⟨10.1038/onc.2009.479⟩. ⟨hal-03030324⟩

Collections

CNRS UP-SCIENCES
8 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More